Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000252879 | SCV000318032 | likely benign | Cardiovascular phenotype | 2016-06-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001079408 | SCV000563342 | benign | Long QT syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000755802 | SCV000883383 | benign | not provided | 2017-08-14 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001174573 | SCV001337735 | benign | not specified | 2020-01-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000755802 | SCV001882192 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253332 | SCV002524855 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000755802 | SCV004164293 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | AKAP9: BP4, BP7 |